Ninety One North America, Inc. Pfizer Inc Transaction History

Ninety One North America, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 24, 2019	SELL	$37.5 - $41.2 $2.32 Million - $2.55 Million	-61,971 Closed	0 $0
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $4.57 Million - $5.21 Million	-118,743 Reduced 65.71%	61,971 $2.71 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $4.09 Million - $4.96 Million	118,743 Added 191.61%	180,714 $7.96 Million
Q2 2018 Aug 10, 2018	BUY	$32.98 - $35.16 $380,918 - $406,097	11,550 Added 22.91%	61,971 $2.25 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $63,788 - $74,002	-1,999 Reduced 3.81%	50,421 $1.79 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $21,452 - $22,762	-645 Reduced 1.22%	52,420 $1.9 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $1.65 Million - $1.81 Million	53,065	53,065 $1.89 Million

3,253

3.72B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Ninety One North America, Inc., based on Form 13F filings with the SEC.

Stay updated on Ninety One North America, Inc. with notifications on news.